533 related articles for article (PubMed ID: 12393418)
1. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.
Pan L; Delmonte J; Jalonen CK; Ferrara JL
Blood; 1995 Dec; 86(12):4422-9. PubMed ID: 8541530
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.
Pan L; Teshima T; Hill GR; Bungard D; Brinson YS; Reddy VS; Cooke KR; Ferrara JL
Blood; 1999 Jun; 93(12):4071-8. PubMed ID: 10361103
[TBL] [Abstract][Full Text] [Related]
4. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice.
O'Keeffe M; Hochrein H; Vremec D; Pooley J; Evans R; Woulfe S; Shortman K
Blood; 2002 Mar; 99(6):2122-30. PubMed ID: 11877288
[TBL] [Abstract][Full Text] [Related]
5. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance.
Morris ES; MacDonald KP; Rowe V; Johnson DH; Banovic T; Clouston AD; Hill GR
Blood; 2004 May; 103(9):3573-81. PubMed ID: 14726406
[TBL] [Abstract][Full Text] [Related]
6. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
7. Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors.
Pan L; Bressler S; Cooke KR; Krenger W; Karandikar M; Ferrara JL
Biol Blood Marrow Transplant; 1996 Oct; 2(3):126-33. PubMed ID: 9199755
[TBL] [Abstract][Full Text] [Related]
8. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation.
Zeng D; Dejbakhsh-Jones S; Strober S
Blood; 1997 Jul; 90(1):453-63. PubMed ID: 9207483
[TBL] [Abstract][Full Text] [Related]
10. Characterization of dendritic cells generated in vivo by an E. coli derived chimeric dual receptor agonist.
Kahn LE; Doshi PD; McGarity KL; Yu M; Bono CP; Lie WR; Rankin AM; Smidt ML; Streeter PR; Klein BK; Welply JK; Woulfe SL
Med Sci Monit; 2002 Dec; 8(12):BR504-14. PubMed ID: 12503028
[TBL] [Abstract][Full Text] [Related]
11. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient.
Reddy V; Hill GR; Pan L; Gerbitz A; Teshima T; Brinson Y; Ferrara JL
Transplantation; 2000 Feb; 69(4):691-3. PubMed ID: 10708136
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.
Arpinati M; Green CL; Heimfeld S; Heuser JE; Anasetti C
Blood; 2000 Apr; 95(8):2484-90. PubMed ID: 10753825
[TBL] [Abstract][Full Text] [Related]
13. Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells.
MacDonald KP; Rowe V; Clouston AD; Welply JK; Kuns RD; Ferrara JL; Thomas R; Hill GR
J Immunol; 2005 Feb; 174(4):1841-50. PubMed ID: 15699110
[TBL] [Abstract][Full Text] [Related]
14. NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.
Morris ES; MacDonald KP; Rowe V; Banovic T; Kuns RD; Don AL; Bofinger HM; Burman AC; Olver SD; Kienzle N; Porcelli SA; Pellicci DG; Godfrey DI; Smyth MJ; Hill GR
J Clin Invest; 2005 Nov; 115(11):3093-103. PubMed ID: 16224535
[TBL] [Abstract][Full Text] [Related]
15. Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease.
Arbez J; Saas P; Lamarthée B; Malard F; Couturier M; Mohty M; Gaugler B
Cytotherapy; 2015 Jul; 17(7):948-55. PubMed ID: 25813681
[TBL] [Abstract][Full Text] [Related]
16. Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.
Lundqvist A; Smith AL; Takahashi Y; Wong S; Bahceci E; Cook L; Ramos C; Tawab A; McCoy JP; Read EJ; Khuu HM; Bolan CD; Joo J; Geller N; Leitman SF; Calandra G; Dunbar C; Kurlander R; Childs RW
J Immunol; 2013 Dec; 191(12):6241-9. PubMed ID: 24244025
[TBL] [Abstract][Full Text] [Related]
17. Progenipoietin-1: a multifunctional agonist of the granulocyte colony-stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells.
Fleming WH; Mulcahy JM; McKearn JP; Streeter PR
Exp Hematol; 2001 Aug; 29(8):943-51. PubMed ID: 11495700
[TBL] [Abstract][Full Text] [Related]
18. Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.
Mochizuki K; Xie F; He S; Tong Q; Liu Y; Mochizuki I; Guo Y; Kato K; Yagita H; Mineishi S; Zhang Y
J Immunol; 2013 Apr; 190(7):3772-82. PubMed ID: 23440416
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia.
Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ
Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363
[TBL] [Abstract][Full Text] [Related]
20. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
Drobyski WR; Majewski D
Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
